Skip to main content

Table 1 Costs by policy option

From: The effect of medical innovation on the cost-effectiveness of Covid 19-related policies in the United States using a SIR model

 

Do Nothing

NMIs Only

Hospital Improvements Only

Vaccines Only

NMIs + Hospital Improvements

NMIs + Vaccines

Hospital Improvements + Vaccines

NMIs + Hospital Improvements + Vaccines

2-year GDP Loss

$500B

$1.7 T

$500B

$500B

$1.7 T

$1.7 T

$500B

$1.7 T

Hospitalization Costs

$59B

$59B

$59B

$52B

$52B

$48B

$52B

$48B

Other NMI Related Economic Costs

$0

$110B

$0

$0

$110B

$110B

$0

$110B

Educational Shutdowns

$0

$523B

$0

$0

$523B

$523B

$0B

$523B

Therapeutic Development

$0

$0

$8.0B

$0

$8.0B

$0

$8.0B

$8.0B

Vaccine Development

$0

$0

$0

$55B

$0

$55B

$55B

$55B

Total Cost

$559B

$2.39 T

$567B

$607B

$2.39 T

$2.44 T

$615B

$2.45 T

  1. NMI Non-Medical Interventions; table reflects the economic costs of different policy options and combinations of policy options by major cost category